Legend Biotech Corp files 6-K detailing Q3 2026 results, showcasing ongoing partnerships with Novartis and Janssen in the pharmaceutical sector.
| Name | Legend Biotech Corp |
|---|---|
| CIK | 0001801198 |
| Tickers | LEGN |
| Exchanges | Nasdaq |
| Entity type | other |
| Category | Large accelerated filer |
| SIC | 2834 Pharmaceutical Preparations |
| EIN | 000000000 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | E9 Cayman Islands |
| Phone | 732-850-5598 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
Legend Biotech Corp files 6-K detailing Q3 2026 results, showcasing ongoing partnerships with Novartis and Janssen in the pharmaceutical sector.
FMR LLC reports a 12.4% ownership stake in Legend Biotech Corp, signaling strong institutional interest in the pharmaceutical preparations sector.
Legend Biotech Corp announces multiple presentations at the 68th American Society of Hematology Annual Meeting, showcasing advances in CARVYKTI and new therapies.
Legend Biotech announces FDA clearance for LB2501, an innovative CAR-T therapy targeting B-cell malignancies, enhancing its position in the pharmaceutical industry.
Legend Biotech announces $710 million in CARVYKTI sales for Q3 2026, highlighting its success in the pharmaceutical preparations industry.
389 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-20 | 4 | xslF345X06/form4-11202026_041101.xml | 0001964342-26-000006 | 5067 | ||||||
| 2026-11-16 | 4 | xslF345X06/form4-11162026_041104.xml | 0002088468-26-000008 | 6780 | ||||||
| 2026-11-10 | 6-K | 6-K | 0001801198-26-000026 | 001-39307 | 261537929 | 34 | 3494199 | 1 | 1 | |
| 2026-11-05 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000315066-26-002770 | 005-92217 | 261526196 | 34 | 11807 | |||
| 2026-11-04 | 6-K | FORM 6-K | 0001171843-26-007100 | 001-39307 | 261520297 | 34 | 61490 | |||
| 2026-10-15 | 6-K | FORM 6-K | 0001171843-26-006646 | 001-39307 | 261461368 | 34 | 16705 | |||
| 2026-10-13 | 6-K | FORM 6-K | 0001171843-26-006593 | 001-39307 | 261454606 | 34 | 15035 | |||
| 2026-10-07 | S-8 | FORM S-8 | 0001171843-26-006498 | 333-299349 | 261447189 | 33 | 330408 | 1 | 1 | |
| 2026-10-01 | 4 | xslF345X06/form4-10012026_081003.xml | 0001796536-26-000010 | 5356 | ||||||
| 2026-09-29 | 144 | xsl144X01/primary_doc.xml | 0001959173-26-007138 | 001-39307 | 261422394 | 33 | 10452 | |||
| 2026-09-28 | 4 | xslF345X06/form4-09282026_040912.xml | 0002088468-26-000006 | 5382 | ||||||
| 2026-09-28 | 4 | xslF345X06/form4-09282026_040909.xml | 0001814673-26-000005 | 5406 | ||||||
| 2026-09-28 | 4 | xslF345X06/form4-09282026_040908.xml | 0002106809-26-000005 | 5368 | ||||||
| 2026-09-28 | 4 | xslF345X06/form4-09282026_040906.xml | 0002068365-26-000009 | 5398 | ||||||
| 2026-09-28 | 4 | xslF345X06/form4-09282026_040904.xml | 0001974687-26-000006 | 5379 | ||||||
| 2026-09-28 | 4 | xslF345X06/form4-09282026_040901.xml | 0001796536-26-000009 | 5424 | ||||||
| 2026-09-25 | 6-K | FORM 6-K | 0001171843-26-006229 | 001-39307 | 261406233 | 34 | 48215 | |||
| 2026-09-24 | 6-K | FORM 6-K | 0001171843-26-006215 | 001-39307 | 261404710 | 34 | 28502 | |||
| 2026-09-23 | 4 | xslF345X06/form4-09232026_040904.xml | 0002097065-26-000005 | 7036 | ||||||
| 2026-09-22 | 144 | xsl144X01/primary_doc.xml | 0001959173-26-007077 | 001-39307 | 261396657 | 33 | 4439 | |||
| 2026-09-22 | 144 | xsl144X01/primary_doc.xml | 0001959173-26-007076 | 001-39307 | 261396402 | 33 | 4869 | |||
| 2026-09-16 | 4 | xslF345X06/form4-09162026_080948.xml | 0001964342-26-000004 | 5349 | ||||||
| 2026-09-16 | 3 | xslF345X06/form3-09162026_080907.xml | 0001964342-26-000003 | 8298 | ||||||
| 2026-09-15 | 6-K | FORM 6-K | 0001171843-26-006050 | 001-39307 | 261379155 | 34 | 28289 | |||
| 2026-09-14 | 6-K | FORM 6-K | 0001171843-26-006027 | 001-39307 | 261375843 | 34 | 580342 | |||
| 2026-08-18 | 4 | xslF345X06/form4-08182026_040805.xml | 0001908421-26-000005 | 5370 | ||||||
| 2026-08-18 | 6-K | FORM 6-K | 0001171843-26-005623 | 001-39307 | 261290480 | 34 | 1632309 | |||
| 2026-08-11 | 6-K | 6-K | 0001801198-26-000022 | 001-39307 | 261260657 | 34 | 3752222 | 1 | 1 | |
| 2026-08-06 | 6-K | FORM 6-K | 0001171843-26-005318 | 001-39307 | 261248852 | 34 | 13629 | |||
| 2026-08-06 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000315066-26-002041 | 005-92217 | 261247097 | 34 | 11759 | |||
| 2026-08-03 | 3 | xslF345X06/form3-08032026_090857.xml | 0001908421-26-000004 | 11466 | ||||||
| 2026-07-27 | 6-K | 6-K | 0001193125-26-316760 | 001-39307 | 261202736 | 34 | 12587 | |||
| 2026-07-15 | 6-K | FORM 6-K | 0001171843-26-004649 | 001-39307 | 261175874 | 34 | 14714 | |||
| 2026-07-02 | 4 | xslF345X06/form4-07022026_040712.xml | 0002068365-26-000005 | 5130 | ||||||
| 2026-07-02 | 4 | xslF345X06/form4-07022026_040714.xml | 0001967360-26-000008 | 5028 | ||||||
| 2026-06-30 | 144 | xsl144X01/primary_doc.xml | 0001959173-26-004966 | 001-39307 | 261138838 | 33 | 5955 | |||
| 2026-06-29 | 4 | xslF345X06/form4-06302026_010610.xml | 0001967360-26-000006 | 5605 | ||||||
| 2026-06-26 | 144 | xsl144X01/primary_doc.xml | 0001959173-26-004918 | 001-39307 | 261128121 | 33 | 5070 | |||
| 2026-06-22 | 6-K | 6-K | 0001193125-26-277556 | 001-39307 | 261107375 | 34 | 324608 | |||
| 2026-06-18 | 424B5 | 424B5 | 0001193125-26-275977 | 333-278050 | 261103318 | 33 | 1115409 | 1 | 1 | |
| 2026-06-17 | 424B5 | 424B5 | 0001193125-26-274318 | 333-278050 | 261099241 | 33 | 972969 | |||
| 2026-06-17 | F-6EF | F-6EF | 0001104659-26-075190 | 333-296862 | 261099124 | 33 | 402104 | |||
| 2026-06-15 | 6-K | FORM 6-K | 0001171843-26-004120 | 001-39307 | 261089076 | 34 | 3712720 | |||
| 2026-06-02 | 6-K | FORM 6-K | 0001171843-26-003866 | 001-39307 | 261053884 | 34 | 51208 | |||
| 2026-06-01 | 6-K | FORM 6-K | 0001171843-26-003825 | 001-39307 | 261047792 | 34 | 51384 | |||
| 2026-05-21 | 6-K | FORM 6-K | 0001171843-26-003622 | 001-39307 | 261009560 | 34 | 52926 | |||
| 2026-05-12 | 6-K | 6-K | 0001801198-26-000014 | 001-39307 | 26965837 | 34 | 3358209 | 1 | 1 | |
| 2026-04-14 | 6-K | FORM 6-K | 0001171843-26-002425 | 001-39307 | 26859162 | 34 | 13384 | |||
| 2026-03-27 | 4 | xslF345X06/form4-03272026_080347.xml | 0001967360-26-000004 | 5537 | ||||||
| 2026-03-26 | 144 | xsl144X01/primary_doc.xml | 0001959173-26-002641 | 001-39307 | 26798636 | 33 | 5070 | |||
| 2026-03-26 | 144 | xsl144X01/primary_doc.xml | 0001959173-26-002640 | 001-39307 | 26798550 | 33 | 4421 | |||
| 2026-03-18 | 3 | xslF345X06/form3-03182026_110339.xml | 0001814673-26-000003 | 13252 | ||||||
| 2026-03-18 | 3 | xslF345X06/form3-03182026_110346.xml | 0002114170-26-000002 | 10186 | ||||||
| 2026-03-18 | 3 | xslF345X06/form3-03182026_110314.xml | 0002088468-26-000003 | 11463 | ||||||
| 2026-03-18 | 3 | xslF345X06/form3-03182026_100355.xml | 0002068365-26-000002 | 12983 | ||||||
| 2026-03-18 | 3 | xslF345X06/form3-03182026_100320.xml | 0002121501-26-000002 | 11242 | ||||||
| 2026-03-18 | 3 | xslF345X06/form3-03182026_100359.xml | 0002106809-26-000002 | 13237 | ||||||
| 2026-03-18 | 3 | xslF345X06/form3-03182026_100337.xml | 0001974687-26-000002 | 13055 | ||||||
| 2026-03-18 | 3 | xslF345X06/form3-03182026_100306.xml | 0001845292-26-000002 | 10124 | ||||||
| 2026-03-18 | 3 | xslF345X06/form3-03182026_100354.xml | 0002097065-26-000002 | 9873 | ||||||
| 2026-03-18 | 3 | xslF345X06/form3-03182026_100321.xml | 0001796536-26-000002 | 12948 | ||||||
| 2026-03-18 | 3 | xslF345X06/form3-03182026_100301.xml | 0001967360-26-000003 | 20654 | ||||||
| 2026-03-18 | 3 | xslF345X06/form3-03182026_100338.xml | 0002114160-26-000002 | 11504 | ||||||
| 2026-03-10 | 20-F | 20-F | 0001801198-26-000008 | 001-39307 | 26737922 | 34 | 65260302 | 1 | 1 | |
| 2026-03-10 | 6-K | FORM 6-K | 0001171843-26-001444 | 001-39307 | 26737118 | 34 | 154764 | |||
| 2026-02-06 | 6-K | FORM 6-K | 0001171843-26-000675 | 001-39307 | 26607474 | 34 | 12855 | |||
| 2026-02-05 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000315066-26-000461 | 005-92217 | 26601952 | 34 | 11636 | |||
| 2026-01-23 | 6-K | FORM 6-K | 0001171843-26-000398 | 001-39307 | 26553356 | 34 | 13931 | |||
| 2026-01-21 | 6-K | FORM 6-K | 0001171843-26-000356 | 001-39307 | 26544797 | 34 | 14531 | |||
| 2026-01-14 | 6-K | FORM 6-K | 0001171843-26-000257 | 001-39307 | 26533280 | 34 | 6537810 | |||
| 2026-01-12 | 6-K | FORM 6-K | 0001171843-26-000206 | 001-39307 | 26524726 | 34 | 34999 | |||
| 2025-12-29 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-007923 | 001-39307 | 251603029 | 33 | 5028 | |||
| 2025-12-29 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-007919 | 001-39307 | 251602838 | 33 | 4424 | |||
| 2025-12-29 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-007917 | 001-39307 | 251602800 | 33 | 5070 | |||
| 2025-12-08 | 6-K | FORM 6-K | 0001171843-25-007796 | 001-39307 | 251554633 | 34 | 52320 | |||
| 2025-11-17 | 144 | xsl144X01/primary_doc.xml | 0001968582-25-001078 | 001-39307 | 251492257 | 33 | 5129 | |||
| 2025-11-12 | 6-K | 6-K | 0001801198-25-000031 | 001-39307 | 251468630 | 34 | 3736104 | 1 | 1 | |
| 2025-11-05 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000315066-25-002798 | 005-92217 | 251452701 | 34 | 11674 | |||
| 2025-11-03 | 6-K | FORM 6-K | 0001171843-25-006904 | 001-39307 | 251443940 | 34 | 56778 | |||
| 2025-10-14 | 6-K | FORM 6-K | 0001171843-25-006414 | 001-39307 | 251389717 | 34 | 14516 | |||
| 2025-10-14 | 6-K | FORM 6-K | 0001171843-25-006413 | 001-39307 | 251389635 | 34 | 15564 | |||
| 2025-10-07 | 6-K | FORM 6-K | 0001171843-25-006329 | 001-39307 | 251379812 | 34 | 14395 | |||
| 2025-09-26 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-006211 | 001-39307 | 251350880 | 33 | 4893 | |||
| 2025-09-24 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-006179 | 001-39307 | 251335631 | 33 | 6834 | |||
| 2025-09-23 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-006168 | 001-39307 | 251333355 | 33 | 6270 | |||
| 2025-09-23 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-006167 | 001-39307 | 251333348 | 33 | 5028 | |||
| 2025-09-23 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-006157 | 001-39307 | 251332106 | 33 | 5029 | |||
| 2025-08-18 | 6-K | FORM 6-K | 0001171843-25-005462 | 001-39307 | 251226302 | 34 | 22757 | |||
| 2025-08-11 | 6-K | 6-K | 0001801198-25-000026 | 001-39307 | 251200092 | 34 | 3810238 | 1 | 1 | |
| 2025-08-06 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000315066-25-002064 | 005-92217 | 251188388 | 34 | 11246 | |||
| 2025-07-23 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-004712 | 001-39307 | 251143244 | 33 | 6784 | |||
| 2025-07-23 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-004703 | 001-39307 | 251142322 | 33 | 4381 | |||
| 2025-07-16 | 6-K | FORM 6-K | 0001171843-25-004480 | 001-39307 | 251126153 | 34 | 14971 | |||
| 2025-06-30 | 6-K | FORM 6-K | 0001171843-25-004224 | 001-39307 | 251092005 | 34 | 11931 | |||
| 2025-06-26 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-004302 | 001-39307 | 251076468 | 33 | 4890 | |||
| 2025-06-25 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-004285 | 001-39307 | 251071573 | 33 | 6231 | |||
| 2025-06-24 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-004278 | 001-39307 | 251069527 | 33 | 5681 | |||
| 2025-06-24 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-004260 | 001-39307 | 251067027 | 33 | 5025 | |||
| 2025-06-12 | 6-K | FORM 6-K | 0001171843-25-003860 | 001-39307 | 251042605 | 34 | 37631 | |||
| 2025-06-06 | 6-K | FORM 6-K | 0001171843-25-003764 | 001-39307 | 251030443 | 34 | 6042985 | |||
| 2025-06-06 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-003860 | 001-39307 | 251029411 | 33 | 4290 | |||
| 2025-06-06 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000315066-25-001640 | 005-92217 | 251029167 | 34 | 11619 | |||
| 2025-06-05 | 6-K | FORM 6-K | 0001171843-25-003703 | 001-39307 | 251025076 | 34 | 16453 | |||
| 2025-06-03 | 6-K | FORM 6-K | 0001171843-25-003621 | 001-39307 | 251017664 | 34 | 61151 | |||
| 2025-05-23 | 6-K | FORM 6-K | 0001171843-25-003412 | 001-39307 | 25978957 | 34 | 119786 | |||
| 2025-05-14 | 6-K | FORM 6-K | 0001171843-25-003155 | 001-39307 | 25942968 | 34 | 13205 | |||
| 2025-05-13 | 6-K | 6-K | 0001801198-25-000021 | 001-39307 | 25937082 | 34 | 3804785 | 1 | 1 | |
| 2025-05-12 | 6-K | 6-K | 0001193125-25-117353 | 001-39307 | 25932747 | 34 | 79771 | |||
| 2025-05-01 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-002778 | 001-39307 | 25900541 | 33 | 5023 | |||
| 2025-04-15 | 6-K | FORM 6-K | 0001171843-25-002203 | 001-39307 | 25837565 | 34 | 15065 | |||
| 2025-03-25 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-002301 | 001-39307 | 25768098 | 33 | 4431 | |||
| 2025-03-25 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-002300 | 001-39307 | 25768063 | 33 | 4471 | |||
| 2025-03-25 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-002295 | 001-39307 | 25766629 | 33 | 4419 | |||
| 2025-03-13 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-002006 | 001-39307 | 25734524 | 33 | 6001 | |||
| 2025-03-11 | 20-F | 20-F | 0001801198-25-000012 | 001-39307 | 25727508 | 34 | 36574044 | 1 | 1 | |
| 2025-03-11 | 6-K | FORM 6-K | 0001171843-25-001386 | 001-39307 | 25725809 | 34 | 128941 | |||
| 2025-02-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000080255-25-000207 | 005-92217 | 25624066 | 34 | 7597 | |||
| 2025-02-12 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000315066-25-000781 | 005-92217 | 25612409 | 34 | 11639 | |||
| 2025-01-22 | 6-K | FORM 6-K | 0001171843-25-000360 | 001-39307 | 25543891 | 34 | 13636 | |||
| 2025-01-14 | 6-K | FORM 6-K | 0001171843-25-000244 | 001-39307 | 25529375 | 34 | 6420989 | |||
| 2025-01-10 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-000243 | 001-39307 | 25522555 | 33 | 4997 | |||
| 2024-12-26 | 144 | xsl144X01/primary_doc.xml | 0001959173-24-008832 | 001-39307 | 241577789 | 33 | 5085 | |||
| 2024-12-26 | 144 | xsl144X01/primary_doc.xml | 0001959173-24-008829 | 001-39307 | 241577532 | 33 | 4390 | |||
| 2024-12-23 | 6-K | FORM 6-K | 0001171843-24-007063 | 001-39307 | 241573525 | 34 | 8711761 | |||
| 2024-12-10 | 6-K | FORM 6-K | 0001171843-24-006838 | 001-39307 | 241536745 | 34 | 49074 | |||
| 2024-12-02 | 144 | xsl144X01/primary_doc.xml | 0001959173-24-008332 | 001-39307 | 241518591 | 33 | 5971 | |||
| 2024-11-14 | SC 13G/A | legn13gasep24.txt | 0000080255-24-001457 | 005-92217 | 34 | 6420 | ||||
| 2024-11-14 | S-8 | S-8 | 0001193125-24-258036 | 333-283217 | 241457460 | 33 | 324828 | 1 | 1 | |
| 2024-11-12 | SC 13G/A | filing.txt | 0000315066-24-002829 | 005-92217 | 241444837 | 34 | 8266 | |||
| 2024-11-12 | 6-K | 6-K | 0001801198-24-000043 | 001-39307 | 241443205 | 34 | 4119215 | 1 | 1 | |
| 2024-11-05 | 6-K | FORM 6-K | 0001171843-24-006009 | 001-39307 | 241425944 | 34 | 52230 | |||
| 2024-10-22 | 6-K | 6-K | 0001193125-24-240752 | 001-39307 | 241384710 | 34 | 10235 | |||
| 2024-10-21 | 6-K | 6-K | 0001193125-24-240395 | 001-39307 | 241383416 | 34 | 29216 | |||
| 2024-10-15 | 6-K | FORM 6-K | 0001171843-24-005616 | 001-39307 | 241369262 | 34 | 12998 | |||
| 2024-09-27 | 6-K | FORM 6-K | 0001171843-24-005381 | 001-39307 | 241335419 | 34 | 51531 | |||
| 2024-09-25 | 144 | xsl144X01/primary_doc.xml | 0001959173-24-006681 | 001-39307 | 241323517 | 33 | 5080 | |||
| 2024-09-20 | 144 | xsl144X01/primary_doc.xml | 0001959173-24-006640 | 001-39307 | 241313885 | 33 | 9851 | |||
| 2024-09-20 | 144 | xsl144X01/primary_doc.xml | 0001959173-24-006630 | 001-39307 | 241312148 | 33 | 4821 | |||
| 2024-09-20 | 6-K | 6-K | 0001193125-24-222460 | 001-39307 | 241311712 | 34 | 137725 | |||
| 2024-09-16 | UPLOAD | filename1.pdf | 0000000000-24-010456 | 001-39307 | 39569 | |||||
| 2024-09-11 | CORRESP | filename1.htm | 0001193125-24-217135 | 16795 | ||||||
| 2024-09-04 | UPLOAD | filename1.pdf | 0000000000-24-010011 | 001-39307 | 45875 | |||||
| 2024-08-27 | 6-K | FORM 6-K | 0001171843-24-004939 | 001-39307 | 241243345 | 34 | 11223 | |||
| 2024-08-09 | 6-K | 6-K | 0001801198-24-000038 | 001-39307 | 241190370 | 34 | 4096154 | 1 | 1 | |
| 2024-08-08 | 6-K | FORM 6-K | 0001171843-24-004605 | 001-39307 | 241188166 | 34 | 15014 | |||
| 2024-07-26 | 6-K | FORM 6-K | 0001171843-24-004161 | 001-39307 | 241143530 | 34 | 21436 | |||
| 2024-07-17 | 6-K | FORM 6-K | 0001171843-24-003984 | 001-39307 | 241120960 | 34 | 15250 | |||
| 2024-07-02 | 6-K | FORM 6-K | 0001171843-24-003760 | 001-39307 | 241092931 | 34 | 46971 | |||
| 2024-06-25 | 144 | xsl144X01/primary_doc.xml | 0001959173-24-004621 | 001-39307 | 241069363 | 33 | 4991 | |||
| 2024-06-25 | 144 | xsl144X01/primary_doc.xml | 0001959173-24-004620 | 001-39307 | 241069284 | 33 | 5080 | |||
| 2024-06-03 | 6-K | FORM 6-K | 0001171843-24-003239 | 001-39307 | 241013567 | 34 | 79134 | |||
| 2024-05-23 | 6-K | FORM 6-K | 0001171843-24-003086 | 001-39307 | 24979377 | 34 | 78079 | |||
| 2024-05-13 | 6-K | 6-K | 0001801198-24-000033 | 001-39307 | 24936834 | 34 | 3935203 | 1 | 1 | |
| 2024-04-22 | 6-K | FORM 6-K | 0001171843-24-002118 | 001-39307 | 24860586 | 34 | 67888 | |||
| 2024-04-16 | 6-K | 6-K | 0001801198-24-000030 | 001-39307 | 24846105 | 34 | 24740 | |||
| 2024-04-08 | 6-K | 6-K | 0001801198-24-000028 | 001-39307 | 24828156 | 34 | 124417 | |||
| 2024-04-05 | SC 13G/A | us52490g1022_040424.txt | 0001086364-24-007351 | 005-92217 | 24825584 | 34 | 12784 | |||
| 2024-03-29 | 6-K | 6-K | 0001801198-24-000026 | 001-39307 | 24802054 | 34 | 26825 | |||
| 2024-03-28 | 144 | xsl144X01/primary_doc.xml | 0001950047-24-002738 | 001-39307 | 24799350 | 33 | 6012 | |||
| 2024-03-27 | 144 | xsl144X01/primary_doc.xml | 0001950047-24-002716 | 001-39307 | 24790812 | 33 | 5321 | |||
| 2024-03-26 | 144 | xsl144X01/primary_doc.xml | 0001950047-24-002707 | 001-39307 | 24784777 | 33 | 4630 | |||
| 2024-03-25 | 144 | xsl144X01/primary_doc.xml | 0001959173-24-002613 | 001-39307 | 24779977 | 33 | 6121 | |||
| 2024-03-25 | 144 | xsl144X01/primary_doc.xml | 0001959173-24-002609 | 001-39307 | 24779616 | 33 | 4239 | |||
| 2024-03-19 | 144 | xsl144X01/primary_doc.xml | 0001959173-24-002468 | 001-39307 | 24761486 | 33 | 4873 | |||
| 2024-03-19 | F-3ASR | F-3ASR | 0001193125-24-070783 | 333-278050 | 24761123 | 33 | 1129734 | |||
| 2024-03-19 | 20-F | 20-F | 0001801198-24-000021 | 001-39307 | 24761065 | 34 | 29307045 | 1 | 1 | |
| 2024-03-15 | 6-K | 6-K | 0001801198-24-000016 | 001-39307 | 24754278 | 34 | 104956 | |||
| 2024-03-13 | 6-K | 6-K | 0001801198-24-000014 | 001-39307 | 24744669 | 34 | 19086 | |||
| 2024-03-11 | 6-K | 6-K | 0001801198-24-000011 | 001-39307 | 24736568 | 34 | 378070 | |||
| 2024-02-28 | 144/A | xsl144X01/primary_doc.xml | 0001959173-24-001556 | 001-39307 | 24697883 | 33 | 7569 | |||
| 2024-02-28 | 144 | xsl144X01/primary_doc.xml | 0001959173-24-001550 | 001-39307 | 24697386 | 33 | 7309 | |||
| 2024-02-27 | 144 | xsl144X01/primary_doc.xml | 0001959173-24-001491 | 001-39307 | 24689448 | 33 | 8385 | |||
| 2024-02-23 | 144 | xsl144X01/primary_doc.xml | 0001959173-24-001330 | 001-39307 | 24669376 | 33 | 4966 | |||
| 2024-02-23 | 6-K | 6-K | 0001801198-24-000006 | 001-39307 | 24667226 | 34 | 105105 | |||
| 2024-02-14 | SC 13G/A | SC 13G/A | 0001193125-24-036760 | 005-92217 | 24641661 | 34 | 35936 | |||
| 2024-02-14 | SC 13G/A | LEGEND BIOTECH CORP | 0000902664-24-001736 | 005-92217 | 24639483 | 34 | 60882 | |||
| 2024-02-14 | SC 13G | legn13gdec23.txt | 0000080255-24-000753 | 005-92217 | 34 | 6418 | ||||
| 2024-02-09 | SC 13G/A | filing.txt | 0000315066-24-001204 | 005-92217 | 24611742 | 34 | 8261 | |||
| 2024-01-29 | SC 13G | us52490g1022_012924.txt | 0001086364-24-005610 | 005-92217 | 24574941 | 34 | 13646 | |||
| 2024-01-23 | 6-K | LEGEND BIOTECH CORPORATION 6-K | 0001157523-24-000092 | 001-39307 | 24550570 | 34 | 15654 | |||
| 2024-01-23 | 6-K | LEGEND BIOTECH CORPORATION 6-K | 0001157523-24-000091 | 001-39307 | 24550483 | 34 | 16405 | |||
| 2024-01-09 | 6-K | LEGEND BIOTECH CORPORATION 6-K | 0001157523-24-000040 | 001-39307 | 24523223 | 34 | 3087938 | |||
| 2023-12-27 | 144 | xsl144X01/primary_doc.xml | 0001959173-23-005724 | 001-39307 | 231515106 | 33 | 4817 | |||
| 2023-12-22 | 144 | xsl144X01/primary_doc.xml | 0001959173-23-005691 | 001-39307 | 231509586 | 33 | 6724 | |||
| 2023-12-22 | 144 | xsl144X01/primary_doc.xml | 0001959173-23-005690 | 001-39307 | 231509514 | 33 | 4847 | |||
| 2023-12-21 | 6-K | LEGEND BIOTECH CORPORATION 6-K | 0001157523-23-001857 | 001-39307 | 231506186 | 34 | 15026 | |||
| 2023-12-21 | 6-K | 6-K | 0001193125-23-301205 | 001-39307 | 231505477 | 34 | 14805 | |||
| 2023-12-12 | 144 | xsl144X01/primary_doc.xml | 0001959173-23-005374 | 001-39307 | 231480838 | 33 | 4224 | |||
| 2023-12-12 | 6-K | LEGEND BIOTECH CORPORATION 6-K | 0001157523-23-001819 | 001-39307 | 231479683 | 34 | 62093 | |||
| 2023-11-20 | 6-K | 6-K | 0001801198-23-000026 | 001-39307 | 231420627 | 34 | 5505159 | 1 | 1 | |
| 2023-11-13 | 6-K | LEGEND BIOTECH CORP. 6-K | 0001157523-23-001718 | 001-39307 | 231395410 | 34 | 32355 | |||
| 2023-10-17 | 144/A | xsl144X01/primary_doc.xml | 0001959173-23-004364 | 001-39307 | 231330501 | 33 | 8653 | |||
| 2023-10-17 | 144 | xsl144X01/primary_doc.xml | 0001959173-23-004363 | 001-39307 | 231330487 | 33 | 8400 | |||
| 2023-10-17 | 6-K | LEGEND BIOTECH CORPORATION 6-K | 0001157523-23-001492 | 001-39307 | 231328466 | 34 | 16632 | |||
| 2023-10-16 | 144 | xsl144X01/primary_doc.xml | 0001959173-23-004340 | 001-39307 | 231328007 | 33 | 8343 | |||
| 2023-09-27 | 144 | xsl144X01/primary_doc.xml | 0001959173-23-004077 | 001-39307 | 231283495 | 33 | 5545 | |||
| 2023-09-25 | 6-K | 6-K | 0001193125-23-240933 | 001-39307 | 231273152 | 34 | 27188 | |||
| 2023-09-22 | 144 | xsl144X01/primary_doc.xml | 0001959173-23-004051 | 001-39307 | 231271953 | 33 | 4765 | |||
| 2023-09-22 | 144 | xsl144X01/primary_doc.xml | 0001959173-23-004049 | 001-39307 | 231271829 | 33 | 5445 | |||
| 2023-09-18 | 144 | xsl144X01/primary_doc.xml | 0001959173-23-003989 | 001-39307 | 231261629 | 33 | 7188 | |||
| 2023-09-15 | UPLOAD | filename1.pdf | 0000000000-23-010246 | 39595 | ||||||
| 2023-09-08 | CORRESP | filename1.htm | 0001193125-23-231191 | 20929 | ||||||
| 2023-08-31 | UPLOAD | filename1.pdf | 0000000000-23-009621 | 46586 | ||||||
| 2023-08-28 | 6-K | LEGEND BIOTECH CORPORATION 6-K | 0001157523-23-001366 | 001-39307 | 231211091 | 34 | 13979 | |||
| 2023-08-23 | 144 | xsl144X01/primary_doc.xml | 0001959173-23-003475 | 001-39307 | 231197937 | 33 | 4234 | |||
| 2023-08-21 | 6-K | 6-K | 0001193125-23-216967 | 001-39307 | 231189259 | 34 | 77181 | |||
| 2023-08-15 | 6-K | 6-K | 0001801198-23-000023 | 001-39307 | 231173139 | 34 | 5493778 | 1 | 1 | |
| 2023-07-20 | 6-K | LEGEND BIOTECH CORPORATION 6-K | 0001157523-23-001114 | 001-39307 | 231098108 | 34 | 17858 | |||
| 2023-06-26 | 144 | xsl144X01/primary_doc.xml | 0001959173-23-002087 | 001-39307 | 231040140 | 33 | 5402 | |||
| 2023-06-22 | 144 | xsl144X01/primary_doc.xml | 0001959173-23-002065 | 001-39307 | 231033300 | 33 | 5966 | |||
| 2023-06-22 | 144 | xsl144X01/primary_doc.xml | 0001959173-23-002064 | 001-39307 | 231033246 | 33 | 7254 | |||
| 2023-06-07 | 144 | xsl144X01/primary_doc.xml | 0001959173-23-001642 | 001-39307 | 23998507 | 33 | 6638 | |||
| 2023-06-06 | 6-K | LEGEND BIOTECH CORPORATION 6-K | 0001157523-23-000941 | 001-39307 | 23996679 | 34 | 68442 | |||
| 2023-06-06 | 144 | xsl144X01/primary_doc.xml | 0001959173-23-001592 | 001-39307 | 23995808 | 33 | 6537 | |||
| 2023-06-05 | 144 | xsl144X01/primary_doc.xml | 0001959173-23-001557 | 001-39307 | 23992779 | 33 | 4793 | |||
| 2023-06-05 | 6-K | LEGEND BIOTECH 6-K | 0001157523-23-000938 | 001-39307 | 23991577 | 34 | 71149 | |||
| 2023-06-02 | 144 | xsl144X01/primary_doc.xml | 0001959173-23-001496 | 001-39307 | 23988698 | 33 | 5443 | |||
| 2023-06-01 | 144 | xsl144X01/primary_doc.xml | 0001959173-23-001470 | 001-39307 | 23984929 | 33 | 4836 | |||
| 2023-05-26 | F-3ASR | F-3ASR | 0001193125-23-154891 | 333-272222 | 23963270 | 33 | 1232986 | |||
| 2023-05-25 | 6-K | LEGEND BIOTECH CORPORATION 6-K | 0001157523-23-000909 | 001-39307 | 23956273 | 34 | 64072 | |||
| 2023-05-18 | 6-K | LEGEND BIOTECH CORPORATION 6-K | 0001157523-23-000881 | 001-39307 | 23933772 | 34 | 382379 | |||
| 2023-05-16 | 6-K | LEGEND BIOTECH CORPORATION 6-K | 0001157523-23-000855 | 001-39307 | 23925670 | 34 | 80919 | |||
| 2023-05-12 | 6-K | LEGEND BIOTECH CORPORATION 6-K | 0001157523-23-000830 | 001-39307 | 23915423 | 34 | 14528 | |||
| 2023-05-10 | SC 13G/A | filing.txt | 0000315066-23-002262 | 005-92217 | 23904692 | 34 | 8138 | |||
| 2023-05-08 | 6-K | 6-K | 0001193125-23-137735 | 001-39307 | 23895998 | 34 | 134159 | |||
| 2023-05-08 | 424B5 | 424B5 | 0001193125-23-137733 | 333-257609 | 23895995 | 33 | 742886 | |||
| 2023-04-28 | D | xslFormDX01/primary_doc.xml | 06b | 0001231919-23-000026 | 021-480374 | 23866146 | 33 | 14462 | ||
| 2023-04-21 | 144 | xsl144X01/primary_doc.xml | 0001959173-23-000662 | 001-39307 | 23836069 | 33 | 5453 | |||
| 2023-04-21 | 6-K | LEGEND BIOTECH CORPORATION 6-K | 0001157523-23-000593 | 001-39307 | 23834650 | 34 | 298434 | |||
| 2023-04-19 | 144 | xsl144X01/primary_doc.xml | 0001959173-23-000626 | 001-39307 | 23829148 | 33 | 5980 | |||
| 2023-04-19 | 6-K | LEGEND BIOTECH CORPORATION 6-K | 0001157523-23-000577 | 001-39307 | 23828628 | 34 | 14226 | |||
| 2023-04-18 | 6-K | LEGEND BIOTECH CORPORATION 6-K | 0001157523-23-000566 | 001-39307 | 23825567 | 34 | 16247 | |||
| 2023-04-14 | 6-K | LEGEND BIOTECH CORPORATION 6-K | 0001157523-23-000551 | 001-39307 | 23819838 | 34 | 402208 | |||
| 2023-04-05 | 144 | xsl144X01/primary_doc.xml | 0001959173-23-000500 | 001-39307 | 23803326 | 33 | 4111 | |||
| 2023-04-05 | 144 | xsl144X01/primary_doc.xml | 0001959173-23-000499 | 001-39307 | 23803302 | 33 | 4139 | |||
| 2023-04-03 | 6-K | LEGEND BIOTECH 6-K | 0001157523-23-000509 | 001-39307 | 23792548 | 34 | 22752 | |||
| 2023-04-03 | 144 | xsl144X01/primary_doc.xml | 0001959173-23-000422 | 001-39307 | 23791510 | 33 | 8425 | |||
| 2023-03-30 | 6-K | LEGEND BIOTECH CORPORATION 6-K | 0001157523-23-000500 | 001-39307 | 23780555 | 34 | 270716 | |||
| 2023-03-30 | 20-F | 20-F | 0001801198-23-000019 | 001-39307 | 23776809 | 34 | 21352600 | 1 | 1 | |
| 2023-02-27 | UPLOAD | filename1.pdf | 0000000000-23-001931 | 39600 | ||||||
| 2023-02-17 | 6-K | 6-K | 0001801198-23-000013 | 001-39307 | 23640277 | 34 | 69440 | |||
| 2023-02-17 | 6-K/A | 6-K/A | 0001801198-23-000011 | 001-39307 | 23640276 | 34 | 367773 | |||
| 2023-02-17 | 20-F/A | 20-F/A | 0001564590-23-002041 | 001-39307 | 23640273 | 34 | 50094991 | 1 | 1 | |
| 2023-02-14 | SC 13G/A | LEGEND BIOTECH CORP | 0000902664-23-001812 | 005-92217 | 23629338 | 34 | 61279 | |||
| 2023-02-14 | SC 13G/A | SC 13G/A | 0001193125-23-039061 | 005-92217 | 23628945 | 34 | 32766 | |||
| 2023-02-14 | SC 13G/A | SC 13G/A | 0001193125-23-039043 | 005-92217 | 23628711 | 34 | 51328 | |||
| 2023-02-14 | SC 13G/A | SC 13G/A | 0001193125-23-039019 | 005-92217 | 23628594 | 34 | 31812 | |||
| 2023-02-09 | SC 13G | filing.txt | 0000315066-23-001818 | 005-92217 | 23603080 | 34 | 8093 | |||
| 2023-01-27 | 6-K | LEGEND BIOTECH CORPORATION 6-K | 0001157523-23-000110 | 001-39307 | 23559781 | 34 | 62806 | |||
| 2023-01-24 | 6-K | LEGEND BIOTECH CORPORATION 6-K | 0001157523-23-000078 | 001-39307 | 23548163 | 34 | 17706 | |||
| 2023-01-09 | 6-K | LEGEND BIOTECH CORPORATION 6-K | 0001157523-23-000031 | 001-39307 | 23516841 | 34 | 21824 | |||
| 2023-01-03 | 6-K | LEGEND BIOTECH CORP. 6-K | 0001157523-23-000002 | 001-39307 | 23500041 | 34 | 53466 | |||
| 2022-12-08 | 6-K | LEGEND BIOTECH CORPORATION 6-K | 0001157523-22-001713 | 001-39307 | 221451444 | 34 | 441170 | |||
| 2022-11-22 | 6-K | LEGEND BIOTECH CORPORATION 6-K | 0001157523-22-001670 | 001-39307 | 221410279 | 34 | 40321 | |||
| 2022-11-21 | 6-K | LEGEND BIOTECH CORP. 6-K | 0001157523-22-001659 | 001-39307 | 221403558 | 34 | 22236 | |||
| 2022-11-04 | 6-K | LEGEND BIOTECH CORPORATION 6-K | 0001157523-22-001534 | 001-39307 | 221362971 | 34 | 18343 | |||
| 2022-11-03 | 6-K | LEGEND BIOTECH CORPORATION 6-K | 0001157523-22-001523 | 001-39307 | 221358048 | 34 | 74793 | |||
| 2022-10-20 | 6-K | LEGEND BIOTECH CORPORATION 6-K | 0001157523-22-001347 | 001-39307 | 221321303 | 34 | 16412 | |||
| 2022-10-18 | 6-K | LEGEND BIOTECH CORPORATION 6-K | 0001157523-22-001333 | 001-39307 | 221316024 | 34 | 17266 | |||
| 2022-10-17 | 6-K | LEGEND BIOTECH CORPORATION 6-K | 0001157523-22-001325 | 001-39307 | 221313800 | 34 | 56093 | |||
| 2022-10-11 | CORRESP | filename1.htm | 0001193125-22-260680 | 40886 | ||||||
| 2022-10-06 | UPLOAD | filename1.pdf | 0000000000-22-011000 | 45229 | ||||||
| 2022-10-03 | 6-K | LEGEND BIOTECH CORPORATION 6-K | 0001157523-22-001279 | 001-39307 | 221287469 | 34 | 141372 | |||
| 2022-09-30 | CORRESP | filename1.htm | 0001564590-22-032968 | 177554 | ||||||
| 2022-09-27 | 6-K | LEGEND BIOTECH CORP. 6-K | 0001157523-22-001265 | 001-39307 | 221267487 | 34 | 61118 | |||
| 2022-09-16 | 6-K | 6-K | 0001564590-22-031793 | 001-39307 | 221248058 | 34 | 901322 | |||
| 2022-09-15 | 6-K | LEGEND BIOTECH CORPORATION 6-K | 0001157523-22-001235 | 001-39307 | 221244532 | 34 | 18943 | |||
| 2022-09-02 | UPLOAD | filename1.pdf | 0000000000-22-009595 | 60731 | ||||||
| 2022-08-19 | 6-K | LEGEND BIOTECH CORPORATION 6-K | 0001157523-22-001145 | 001-39307 | 221180732 | 34 | 18226 | |||
| 2022-08-05 | 6-K | LEGEND BIOTECH CORP. 6-K | 0001157523-22-001061 | 001-39307 | 221138725 | 34 | 37306 | |||
| 2022-08-04 | 6-K | FORM 6-K | 0001193125-22-212542 | 001-39307 | 221136868 | 34 | 154287 | |||
| 2022-07-27 | 6-K | 6-K | 0001193125-22-203478 | 001-39307 | 221111463 | 34 | 260090 | |||
| 2022-07-27 | 424B5 | 424B5 | 0001193125-22-203470 | 333-257609 | 221111437 | 33 | 1083427 | |||
| 2022-07-25 | 424B5 | 424B5 | 0001193125-22-200891 | 333-257609 | 221103694 | 33 | 1049399 | |||
| 2022-07-25 | 6-K | FORM 6-K | 0001193125-22-200851 | 001-39307 | 221103414 | 34 | 1100628 | |||
| 2022-07-21 | 6-K | LEGEND BIOTECH CORPORATION 6-K | 0001157523-22-000879 | 001-39307 | 221095481 | 34 | 13606 | |||
| 2022-07-13 | 6-K | LEGEND BIOTECH CORPORATION FORM 6-K | 0001157523-22-000841 | 001-39307 | 221080241 | 34 | 27175 | |||
| 2022-07-07 | 6-K | LEGEND BIOTECH CORPORATION FORM 6-K | 0001157523-22-000824 | 001-39307 | 221070687 | 34 | 16330 | |||
| 2022-06-06 | 6-K | LEGEND BIOTECH CORPORATION FORM 6-K | 0001157523-22-000727 | 001-39307 | 22996618 | 34 | 67703 | |||
| 2022-06-03 | 6-K | LEGEND BIOTECH CORP. 6-K | 0001157523-22-000722 | 001-39307 | 22992964 | 34 | 27746 | |||
| 2022-06-02 | 6-K | LEGEND BIOTECH CORP. 6-K | 0001157523-22-000717 | 001-39307 | 22990499 | 34 | 23736 | |||
| 2022-06-01 | 6-K | LEGEND BIOTECH CORPORATION 6-K | 0001157523-22-000714 | 001-39307 | 22986045 | 34 | 336641 | |||
| 2022-05-26 | 6-K | LEGEND BIOTECH CORP. 6-K | 0001157523-22-000692 | 001-39307 | 22965407 | 34 | 44174 | |||
| 2022-05-18 | 6-K | LEGEND BIOTECH CORP. 6-K | 0001157523-22-000654 | 001-39307 | 22937126 | 34 | 74467 | |||
| 2022-05-09 | 6-K | LEGEND BIOTECH CORPORATION 6-K | 0001157523-22-000586 | 001-39307 | 22903158 | 34 | 21994 | |||
| 2022-05-09 | 6-K | LEGEND BIOTECH CORPORATION 6-K | 0001157523-22-000585 | 001-39307 | 22903154 | 34 | 17646 | |||
| 2022-05-06 | 6-K | LEGEND BIOTECH CORPORATION 6-K | 0001157523-22-000583 | 001-39307 | 22900964 | 34 | 21898 | |||
| 2022-04-21 | 6-K | LEGEND BIOTECH CORPORATION 6-K | 0001157523-22-000455 | 001-39307 | 22839748 | 34 | 22616 | |||
| 2022-04-13 | 6-K | LEGEND BIOTECH CORPORATION FORM 6-K | 0001157523-22-000423 | 001-39307 | 22825481 | 34 | 14821 | |||
| 2022-04-01 | 6-K | LEGEND BIOTECH CORP. 6-K | 0001157523-22-000387 | 001-39307 | 22798137 | 34 | 24752 | |||
| 2022-03-31 | 20-F | 20-F | 0001564590-22-012769 | 001-39307 | 22789198 | 34 | 32119127 | 1 | 1 | |
| 2022-03-25 | 6-K | LEGEND BIOTECH CORPORATION 6-K | 0001157523-22-000367 | 001-39307 | 22768294 | 34 | 32118 | |||
| 2022-03-18 | 6-K | LEGEND BIOTECH CORPORATION 6-K | 0001157523-22-000354 | 001-39307 | 22752633 | 34 | 362839 | |||
| 2022-03-11 | SC 13G/A | SC 13G/A | 0001193125-22-073523 | 005-92217 | 22733939 | 34 | 36438 | |||
| 2022-03-07 | 6-K | LEGEND BIOTECH CORP. 6-K | 0001157523-22-000291 | 001-39307 | 22716117 | 34 | 14246 | |||
| 2022-03-01 | 6-K | LEGEND BIOTECH CORP. 6-K | 0001157523-22-000274 | 001-39307 | 22693670 | 34 | 55567 | |||
| 2022-02-18 | 6-K | LEGEND BIOTECH CORPORATION 6-K | 0001157523-22-000221 | 001-39307 | 22650935 | 34 | 35220 | |||
| 2022-02-15 | 6-K | LEGEND BIOTECH CORPORATION 6-K | 0001157523-22-000203 | 001-39307 | 22637122 | 34 | 22461 | |||
| 2022-02-14 | SC 13G/A | LEGEND BIOTECH CORP | 0000902664-22-001729 | 005-92217 | 22631868 | 34 | 63170 | |||
| 2022-02-11 | 6-K | LEGEND BIOTECH CORPORATION 6-K | 0001157523-22-000187 | 001-39307 | 22616899 | 34 | 22271 | |||
| 2022-02-02 | 6-K | LEGEND BIOTECH CORPORATION 6-K | 0001157523-22-000136 | 001-39307 | 22583551 | 34 | 11661 | |||
| 2022-01-04 | 6-K | LEGEND BIOTECH CORPORATION FORM 6-K | 0001157523-22-000008 | 001-39307 | 22504166 | 34 | 18962 | |||
| 2021-12-30 | 6-K | LEGEND BIOTECH CORPORATION 6-K | 0001157523-21-001530 | 001-39307 | 211530660 | 34 | 18644 | |||
| 2021-12-17 | 6-K | 6-K | 0001193125-21-361131 | 001-39307 | 211501820 | 34 | 350634 | |||
| 2021-12-17 | 424B5 | 424B5 | 0001193125-21-361120 | 333-257609 | 211501775 | 33 | 1257464 | |||
| 2021-12-16 | FWP | FWP | 0001193125-21-358617 | 333-257609 | 211496044 | 34 | 13283 | |||
| 2021-12-14 | 424B5 | 424B5 | 0001193125-21-356850 | 333-257609 | 211491489 | 33 | 1251968 | |||
| 2021-12-14 | 6-K | 6-K | 0001193125-21-356822 | 001-39307 | 211491285 | 34 | 709879 | |||
| 2021-12-13 | 6-K | LEGEND BIOTECH CORPORATION 6-K | 0001157523-21-001495 | 001-39307 | 211487089 | 34 | 45189 | |||
| 2021-12-07 | 6-K | LEGEND BIOTECH CORPORATION FORM 6-K | 0001157523-21-001483 | 001-39307 | 211474777 | 34 | 27366 | |||
| 2021-12-06 | 6-K | LEGEND BIOTECH CORPORATION 6-K | 0001157523-21-001479 | 001-39307 | 211472109 | 34 | 33271 | |||
| 2021-11-16 | 6-K | LEGEND BIOTECH CORP. 6-K | 0001157523-21-001420 | 001-39307 | 211414187 | 34 | 400573 | |||
| 2021-11-04 | 6-K | LEGEND BIOTECH CORP. 6-K | 0001157523-21-001337 | 001-39307 | 211378180 | 34 | 52775 | |||
| 2021-11-01 | 6-K | LEGEND BIOTECH CORPORATION 6-K | 0001157523-21-001295 | 001-39307 | 211367084 | 34 | 28017 | |||
| 2021-10-18 | 6-K | LEGEND BIOTECH CORPORATION 6-K | 0001157523-21-001213 | 001-39307 | 211327392 | 34 | 23473 | |||
| 2021-09-22 | 6-K | LEGEND BIOTECH CORPORATION 6-K | 0001157523-21-001158 | 001-39307 | 211268220 | 34 | 16862 | |||
| 2021-09-13 | 6-K | LEGEND BIOTECH CORPORATION 6-K | 0001157523-21-001135 | 001-39307 | 211248764 | 34 | 7296853 | |||
| 2021-08-30 | 6-K | LEGEND BIOTECH CORPORATION FORM 6-K | 0001157523-21-001102 | 001-39307 | 211221130 | 34 | 15917 | |||
| 2021-08-23 | 6-K | 6-K | 0001564590-21-045342 | 001-39307 | 211195416 | 34 | 10676823 | 1 | ||
| 2021-08-23 | 6-K | LEGEND BIOTECH CORPORATION 6-K | 0001157523-21-001084 | 001-39307 | 211195396 | 34 | 202856 | |||
| 2021-07-14 | 424B3 | 424B3 | 0001193125-21-215226 | 333-257625 | 211090295 | 33 | 368456 | |||
| 2021-07-13 | EFFECT | xslEFFECTX01/primary_doc.xml | F-3,,2021-07-13 14:00:00 | 9999999995-21-002741 | 333-257625 | 211089196 | 33 | 1660 | ||
| 2021-07-12 | SC 13G | LEGEND BIOTECH CORP | 0000902664-21-003475 | 005-92217 | 211085677 | 34 | 41448 | |||
| 2021-07-09 | CORRESP | filename1.htm | 0001193125-21-211641 | 5751 | ||||||
| 2021-07-08 | UPLOAD | filename1.pdf | 0000000000-21-008394 | 39970 | ||||||
| 2021-07-02 | F-3 | F-3 | 0001193125-21-207037 | 333-257625 | 211067992 | 33 | 991922 | |||
| 2021-07-01 | F-3ASR | F-3ASR | 0001193125-21-206350 | 333-257609 | 211066307 | 33 | 843029 | |||
| 2021-06-22 | 6-K | LEGEND BIOTECH CORPORATION 6-K | 0001157523-21-000815 | 001-39307 | 211033089 | 34 | 7302208 | |||
| 2021-06-10 | 6-K | LEGEND BIOTECH CORPORATION 6-K | 0001157523-21-000763 | 001-39307 | 211006932 | 34 | 41748 | |||
| 2021-06-09 | 6-K | LEGEND BIOTECH CORPORATION 6-K | 0001157523-21-000756 | 001-39307 | 211004024 | 34 | 7047821 | |||
| 2021-06-01 | 6-K | LEGEND BIOTECH CORP. 6-K | 0001157523-21-000728 | 001-39307 | 21983102 | 34 | 34847 | |||
| 2021-05-27 | 6-K | 6-K | 0001193125-21-173841 | 001-39307 | 21967847 | 34 | 39241 | |||
| 2021-05-25 | 6-K | LEGEND BIOTECH CORPORATION 6-K | 0001157523-21-000713 | 001-39307 | 21958362 | 34 | 13272 | |||
| 2021-05-20 | 6-K | 6-K | 0001193125-21-167603 | 001-39307 | 21943845 | 34 | 9901 | |||
| 2021-05-18 | 6-K | 6-K | 0001193125-21-164633 | 001-39307 | 21933933 | 34 | 114290 | |||
| 2021-05-13 | 6-K | 6-K | 0001193125-21-160541 | 001-39307 | 21920062 | 34 | 11532 | |||
| 2021-05-12 | 6-K | 6-K | 0001193125-21-158777 | 001-39307 | 21914621 | 34 | 52860 | |||
| 2021-05-05 | 6-K | 6-K | 0001193125-21-150941 | 001-39307 | 21891303 | 34 | 72465 | |||
| 2021-04-30 | 6-K | 6-K | 0001193125-21-142406 | 001-39307 | 21873658 | 34 | 46275 | |||
| 2021-04-02 | 20-F | 20-F | 0001564590-21-017439 | 001-39307 | 21800539 | 34 | 25839306 | 1 | ||
| 2021-03-18 | 6-K | LEGEND BIOTECH CORPORATION 6-K | 0001157523-21-000358 | 001-39307 | 21753051 | 34 | 3003473 | |||
| 2021-03-10 | 6-K | LEGEND BIOTECH CORPORATION 6-K | 0001157523-21-000325 | 001-39307 | 21730193 | 34 | 14946 | |||
| 2021-02-19 | 6-K | LEGEND BIOTECH CORP. 6-K | 0001157523-21-000225 | 001-39307 | 21652057 | 34 | 30368 | |||
| 2021-02-16 | SC 13G | SC 13G | 0001193125-21-043384 | 005-92217 | 21632474 | 34 | 31121 | |||
| 2021-02-16 | SC 13G | SC 13G | 0001193125-21-043372 | 005-92217 | 21632448 | 34 | 53781 | |||
| 2021-02-16 | SC 13G | SC 13G | 0001193125-21-043362 | 005-92217 | 21632425 | 34 | 34327 | |||
| 2021-02-01 | 6-K | LEGEND BIOTECH CORPORATION 6-K | 0001157523-21-000115 | 001-39307 | 21574333 | 34 | 26496 | |||
| 2021-01-11 | 6-K | LEGEND BIOTECH CORPORATION 6-K | 0001157523-21-000036 | 001-39307 | 21521167 | 34 | 5354367 | |||
| 2020-12-30 | 6-K | 6-K | 0001193125-20-329143 | 001-39307 | 201423999 | 34 | 37400 | |||
| 2020-12-21 | 6-K | 6-K | 0001193125-20-322320 | 001-39307 | 201402389 | 34 | 35338 | |||
| 2020-12-14 | 6-K | 6-K | 0001193125-20-317021 | 001-39307 | 201386662 | 34 | 21356 | |||
| 2020-12-14 | 6-K | 6-K | 0001193125-20-316434 | 001-39307 | 201385138 | 34 | 29830 | |||
| 2020-12-07 | 6-K | 6-K | 0001193125-20-311114 | 001-39307 | 201371284 | 34 | 48170 | |||
| 2020-12-03 | 6-K | 6-K | 0001193125-20-309023 | 001-39307 | 201365735 | 34 | 26391 | |||
| 2020-11-24 | 6-K | 6-K | 0001193125-20-302058 | 001-39307 | 201339978 | 34 | 29427 | |||
| 2020-11-23 | 6-K | 6-K | 0001193125-20-300418 | 001-39307 | 201334252 | 34 | 28358 | |||
| 2020-11-16 | 6-K | 6-K | 0001193125-20-293750 | 001-39307 | 201313631 | 34 | 200580 | |||
| 2020-11-09 | 6-K | 6-K | 0001193125-20-288530 | 001-39307 | 201296195 | 34 | 190020 | |||
| 2020-11-05 | 6-K | 6-K | 0001193125-20-286207 | 001-39307 | 201288652 | 34 | 44017 | |||
| 2020-09-21 | 6-K | 6-K | 0001193125-20-249677 | 001-39307 | 201185190 | 34 | 30861 | |||
| 2020-09-04 | S-8 POS | S-8 POS | 0001193125-20-240097 | 333-239478 | 201162063 | 33 | 163532 | |||
| 2020-08-31 | 6-K | 6-K | 0001193125-20-235287 | 001-39307 | 201149701 | 34 | 130703 | |||
| 2020-08-06 | 6-K | 6-K | 0001193125-20-211224 | 001-39307 | 201079627 | 34 | 56723 | |||
| 2020-08-03 | 6-K | 6-K | 0001193125-20-207197 | 001-39307 | 201067734 | 34 | 27212 | |||
| 2020-08-03 | 6-K | 6-K | 0001193125-20-207190 | 001-39307 | 201067722 | 34 | 30998 | |||
| 2020-07-16 | 6-K | 6-K | 0001193125-20-193728 | 001-39307 | 201030775 | 34 | 11879 | |||
| 2020-06-26 | S-8 | S-8 | 0001193125-20-180940 | 333-239478 | 20994263 | 33 | 1028932 | |||
| 2020-06-08 | 424B4 | 424B4 | 0001193125-20-162919 | 333-238232 | 20948233 | 33 | 5281528 | |||
| 2020-06-04 | EFFECT | xslEFFECTX01/primary_doc.xml | F-6,,2020-06-04 16:00:00 | 9999999995-20-001339 | 333-238581 | 20944402 | 33 | 1659 | ||
| 2020-06-04 | EFFECT | xslEFFECTX01/primary_doc.xml | F-1,,2020-06-04 16:00:00 | 9999999995-20-001333 | 333-238232 | 20944405 | 33 | 1659 | ||
| 2020-06-03 | CERT | 8A_Cert_LEGN.pdf | 0001354457-20-000216 | 001-39307 | 20939323 | 34 | 90115 | |||
| 2020-06-02 | CORRESP | filename1.htm | 0001193125-20-158461 | 20048 | ||||||
| 2020-06-02 | CORRESP | filename1.htm | 0001193125-20-158459 | 14301 | ||||||
| 2020-06-02 | 8-A12B | 8-A12B | 0001193125-20-158448 | 001-39307 | 20936919 | 34 | 16162 | |||
| 2020-05-29 | F-6/A | F-6/A | 0001193125-20-155321 | 333-238581 | 20925359 | 33 | 54717 | |||
| 2020-05-29 | F-1/A | F-1/A | 0001193125-20-155054 | 333-238232 | 20924146 | 33 | 6669097 | |||
| 2020-05-21 | F-6 | F-6 | 0001193125-20-148812 | 333-238581 | 20902845 | 33 | 440561 | |||
| 2020-05-21 | CORRESP | filename1.htm | 0001193125-20-148630 | 40993 | ||||||
| 2020-05-20 | UPLOAD | filename1.pdf | 0000000000-20-004487 | 49862 | ||||||
| 2020-05-19 | CORRESP | filename1.htm | 0001193125-20-145827 | 52521 | ||||||
| 2020-05-13 | F-1 | F-1 | 0001193125-20-141663 | 333-238232 | 20873727 | 33 | 6694534 | |||
| 2020-05-08 | DRSLTR | filename1.htm | 0000950123-20-004168 | 48502 | ||||||
| 2020-05-08 | DRS/A | filename1.htm | 0000950123-20-004167 | 377-03085 | 20859113 | 33 | 5556451 | |||
| 2020-05-01 | UPLOAD | filename1.pdf | 0000000000-20-003791 | 51278 | ||||||
| 2020-04-20 | DRSLTR | filename1.htm | 0000950123-20-003472 | 77635 | ||||||
| 2020-04-20 | DRS/A | filename1.htm | 0000950123-20-003471 | 377-03085 | 20802146 | 33 | 4936945 | |||
| 2020-04-07 | D | xslFormDX01/primary_doc.xml | 06b | 0001288320-20-000003 | 021-364441 | 20778877 | 33 | 8330 | ||
| 2020-04-02 | UPLOAD | filename1.pdf | 0000000000-20-002877 | 63469 | ||||||
| 2020-03-09 | DRS | filename1.htm | 0000950123-20-002800 | 377-03085 | 20697037 | 33 | 4792880 |
One latest value per concept from companyfacts (257 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 369.89M | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 | |
| ffd | NetFeeAmt | NetFeeAmt | USD | 15,271.02 | 2026-10-06 | S-8 | 2026-10-07 | 0001171843-26-006498 | |||
| ffd | NrrtvMaxAggtOfferingPric | NrrtvMaxAggtOfferingPric | USD | 259.98M | 2026-06-18 | 424B5 | 2026-06-18 | 0001193125-26-275977 | |||
| ffd | TtlFeeAmt | TtlFeeAmt | USD | 15,271.02 | 2026-10-06 | S-8 | 2026-10-07 | 0001171843-26-006498 | |||
| ffd | TtlOfferingAmt | TtlOfferingAmt | USD | 175.53M | 2026-10-06 | S-8 | 2026-10-07 | 0001171843-26-006498 | |||
| ffd | TtlOffsetAmt | TtlOffsetAmt | USD | 0 | 2026-10-06 | S-8 | 2026-10-07 | 0001171843-26-006498 | |||
| ffd | TtlPrevslyPdAmt | TtlPrevslyPdAmt | USD | 0 | 2026-06-18 | 424B5 | 2026-06-18 | 0001193125-26-275977 | |||
| ifrs-full | AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment | AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment | USD | 28.82M | 2021-01-01 | 2021-06-30 | 6-K | 2021-08-23 | 0001564590-21-045342 | ||
| ifrs-full | AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill | AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 20-F | 2025-03-11 | 0001801198-25-000012 |
| ifrs-full | AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment | AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment | USD | 26.70M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | AdditionsToRightofuseAssets | AdditionsToRightofuseAssets | USD | 195.70M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | AdjustedWeightedAverageShares | AdjustedWeightedAverageShares | shares | 368.64M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | AdjustmentsForAmortisationExpense | AdjustmentsForAmortisationExpense | USD | 228,000 | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-08-11 | 0001801198-25-000026 |
| ifrs-full | AdjustmentsForCurrentTaxOfPriorPeriod | AdjustmentsForCurrentTaxOfPriorPeriod | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 20-F | 2023-03-30 | 0001801198-23-000019 |
| ifrs-full | AdjustmentsForDecreaseIncreaseInInventories | AdjustmentsForDecreaseIncreaseInInventories | USD | -4.50M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | AdjustmentsForDecreaseIncreaseInOtherCurrentAssets | AdjustmentsForDecreaseIncreaseInOtherCurrentAssets | USD | -1.18M | 2021-01-01 | 2021-12-31 | 2021 | FY | 20-F/A | 2023-02-17 | 0001564590-23-002041 |
| ifrs-full | AdjustmentsForDecreaseIncreaseInTradeAccountReceivable | AdjustmentsForDecreaseIncreaseInTradeAccountReceivable | USD | -5.70M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | AdjustmentsForDepreciationExpense | AdjustmentsForDepreciationExpense | USD | 9.40M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | AdjustmentsForFairValueGainsLosses | AdjustmentsForFairValueGainsLosses | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | AdjustmentsForFinanceCosts | AdjustmentsForFinanceCosts | USD | 21.40M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | AdjustmentsForFinanceIncome | AdjustmentsForFinanceIncome | USD | 40.10M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss | AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossInventories | AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossInventories | USD | 6,000 | 2021-01-01 | 2021-06-30 | 6-K | 2021-08-23 | 0001564590-21-045342 | ||
| ifrs-full | AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossTradeAndOtherReceivables | AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossTradeAndOtherReceivables | USD | -22,000 | 2021-01-01 | 2021-12-31 | 2021 | FY | 20-F | 2022-03-31 | 0001564590-22-012769 |
| ifrs-full | AdjustmentsForIncreaseDecreaseInContractLiabilities | AdjustmentsForIncreaseDecreaseInContractLiabilities | USD | -40.00M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | AdjustmentsForIncreaseDecreaseInOtherOperatingPayables | AdjustmentsForIncreaseDecreaseInOtherOperatingPayables | USD | 36.10M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables | AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables | USD | 44.40M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | AdjustmentsForUnrealisedForeignExchangeLossesGains | AdjustmentsForUnrealisedForeignExchangeLossesGains | USD | 168.80M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | AdministrativeExpense | AdministrativeExpense | USD | 135.80M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | AllowanceAccountForCreditLossesOfFinancialAssets | AllowanceAccountForCreditLossesOfFinancialAssets | USD | 22,000 | 2020-12-31 | 2021 | FY | 20-F | 2022-03-31 | 0001564590-22-012769 | |
| ifrs-full | AmortisationIntangibleAssetsOtherThanGoodwill | AmortisationIntangibleAssetsOtherThanGoodwill | USD | 1.93M | 2024-01-01 | 2024-12-31 | 2024 | FY | 20-F | 2025-03-11 | 0001801198-25-000012 |
| ifrs-full | Assets | Assets | USD | 1.73B | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 | |
| ifrs-full | AverageEffectiveTaxRate | AverageEffectiveTaxRate | pure | -0.05 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | BasicAndDilutedEarningsLossPerShare | BasicAndDilutedEarningsLossPerShare | USD/shares | -0.63 | 2021-01-01 | 2021-06-30 | 6-K | 2021-08-23 | 0001564590-21-045342 | ||
| ifrs-full | BasicEarningsLossPerShare | BasicEarningsLossPerShare | USD/shares | -0.81 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | Borrowings | Borrowings | USD | 319.10M | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 | |
| ifrs-full | BorrowingsAdjustmentToInterestRateBasis | BorrowingsAdjustmentToInterestRateBasis | pure | 0.025 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 | |
| ifrs-full | BorrowingsInterestRate | BorrowingsInterestRate | pure | 0.067 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 | |
| ifrs-full | Cash | Cash | USD | 948.60M | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 | |
| ifrs-full | CashAdvancesAndLoansFromRelatedParties | CashAdvancesAndLoansFromRelatedParties | USD | 38.95M | 2019-01-01 | 2019-12-31 | 2021 | FY | 20-F/A | 2023-02-17 | 0001564590-23-002041 |
| ifrs-full | CashAdvancesAndLoansMadeToRelatedParties | CashAdvancesAndLoansMadeToRelatedParties | USD | 13.01M | 2019-01-01 | 2019-12-31 | 2021 | FY | 20-F/A | 2023-02-17 | 0001564590-23-002041 |
| ifrs-full | CashAndBankBalancesAtCentralBanks | CashAndBankBalancesAtCentralBanks | USD | 948.60M | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 | |
| ifrs-full | CashAndCashEquivalents | CashAndCashEquivalents | USD | 901.90M | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 | |
| ifrs-full | CashFlowsFromUsedInFinancingActivities | CashFlowsFromUsedInFinancingActivities | USD | -300,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | CashFlowsFromUsedInInvestingActivities | CashFlowsFromUsedInInvestingActivities | USD | 709.60M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | CashFlowsFromUsedInOperatingActivities | CashFlowsFromUsedInOperatingActivities | USD | -100.20M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | CashFlowsFromUsedInOperations | CashFlowsFromUsedInOperations | USD | -138.36M | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-08-11 | 0001801198-25-000026 |
| ifrs-full | CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital | CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital | USD | -40.70M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | CashOutflowForLeases | CashOutflowForLeases | USD | 10.80M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | CashReceiptsFromRepaymentOfAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities | CashReceiptsFromRepaymentOfAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities | USD | 39,000 | 2020-01-01 | 2020-06-30 | 6-K | 2021-08-23 | 0001564590-21-045342 | ||
| ifrs-full | CashReceiptsFromRepaymentOfAdvancesAndLoansMadeToRelatedParties | CashReceiptsFromRepaymentOfAdvancesAndLoansMadeToRelatedParties | USD | 63.00M | 2019-01-01 | 2019-12-31 | 2021 | FY | 20-F/A | 2023-02-17 | 0001564590-23-002041 |
| ifrs-full | CashRepaymentsOfAdvancesAndLoansFromRelatedParties | CashRepaymentsOfAdvancesAndLoansFromRelatedParties | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 20-F | 2023-03-30 | 0001801198-23-000019 |
| ifrs-full | ComprehensiveIncome | ComprehensiveIncome | USD | -106.40M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | ComprehensiveIncomeAttributableToOwnersOfParent | ComprehensiveIncomeAttributableToOwnersOfParent | USD | -40.19M | 2025-01-01 | 2025-03-31 | 2025 | Q1 | 6-K | 2025-05-13 | 0001801198-25-000021 |
| ifrs-full | ConstructionInProgress | ConstructionInProgress | USD | 23.95M | 2021-06-30 | 6-K | 2021-08-23 | 0001564590-21-045342 | |||
| ifrs-full | ContractLiabilities | ContractLiabilities | USD | 39.53M | 2025-03-31 | 2025 | Q1 | 6-K | 2025-05-13 | 0001801198-25-000021 | |
| ifrs-full | CostOfSales | CostOfSales | USD | 397.10M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | CurrentAndDeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity | CurrentAndDeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity | USD | 14.20M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | CurrentAssets | CurrentAssets | USD | 1.25B | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 | |
| ifrs-full | CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings | CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings | USD | 319.10M | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 | |
| ifrs-full | CurrentContractLiabilities | CurrentContractLiabilities | USD | 11.30M | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 | |
| ifrs-full | CurrentDerivativeFinancialLiabilities | CurrentDerivativeFinancialLiabilities | USD | 0 | 2023-12-31 | 2023 | FY | 20-F | 2024-03-19 | 0001801198-24-000021 | |
| ifrs-full | CurrentFinanceLeaseReceivables | CurrentFinanceLeaseReceivables | USD | 94,000 | 2021-12-31 | 2021 | FY | 20-F/A | 2023-02-17 | 0001564590-23-002041 | |
| ifrs-full | CurrentFinancialAssetsAtAmortisedCost | CurrentFinancialAssetsAtAmortisedCost | USD | 29.85M | 2021-06-30 | 6-K | 2021-08-23 | 0001564590-21-045342 | |||
| ifrs-full | CurrentFinancialAssetsAtFairValueThroughProfitOrLoss | CurrentFinancialAssetsAtFairValueThroughProfitOrLoss | USD | 5.00M | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 | |
| ifrs-full | CurrentGovernmentGrants | CurrentGovernmentGrants | USD | 651,000 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-08-11 | 0001801198-25-000026 | |
| ifrs-full | CurrentLeaseLiabilities | CurrentLeaseLiabilities | USD | 7.40M | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 | |
| ifrs-full | CurrentLiabilities | CurrentLiabilities | USD | 636.40M | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 | |
| ifrs-full | CurrentPrepaymentsAndOtherCurrentAssets | CurrentPrepaymentsAndOtherCurrentAssets | USD | 253.40M | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 | |
| ifrs-full | CurrentRawMaterialsAndCurrentProductionSupplies | CurrentRawMaterialsAndCurrentProductionSupplies | USD | 1.75M | 2021-12-31 | 2021 | FY | 20-F/A | 2023-02-17 | 0001564590-23-002041 | |
| ifrs-full | CurrentTaxLiabilities | CurrentTaxLiabilities | USD | 19.20M | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 | |
| ifrs-full | CurrentTaxRelatingToItemsChargedOrCreditedDirectlyToEquity | CurrentTaxRelatingToItemsChargedOrCreditedDirectlyToEquity | USD | 1,000 | 2021-01-01 | 2021-06-30 | 6-K | 2021-08-23 | 0001564590-21-045342 | ||
| ifrs-full | CurrentTradeReceivables | CurrentTradeReceivables | USD | 13.10M | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 | |
| ifrs-full | DecreaseThroughPerformanceObligationBeingSatisfiedContractLiabilities | DecreaseThroughPerformanceObligationBeingSatisfiedContractLiabilities | USD | 52.50M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised | DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised | USD | 586.60M | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 | |
| ifrs-full | DeferredTaxAssets | DeferredTaxAssets | USD | 20.20M | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 | |
| ifrs-full | DeferredTaxExpenseIncomeRecognisedInProfitOrLoss | DeferredTaxExpenseIncomeRecognisedInProfitOrLoss | USD | -8.04M | 2021-01-01 | 2021-12-31 | 2021 | FY | 20-F/A | 2023-02-17 | 0001564590-23-002041 |
| ifrs-full | DeferredTaxLiabilities | DeferredTaxLiabilities | USD | 20.20M | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 | |
| ifrs-full | DeferredTaxLiabilityAsset | DeferredTaxLiabilityAsset | USD | 4.24M | 2020-12-31 | 2021 | FY | 20-F/A | 2023-02-17 | 0001564590-23-002041 | |
| ifrs-full | DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity | DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | DepreciationPropertyPlantAndEquipment | DepreciationPropertyPlantAndEquipment | USD | 9.40M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | DepreciationRightofuseAssets | DepreciationRightofuseAssets | USD | 19.50M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | DescriptionOfExpectedVolatilityShareOptionsGranted | DescriptionOfExpectedVolatilityShareOptionsGranted | pure | 0.59 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | DescriptionOfOptionLifeShareOptionsGranted | DescriptionOfOptionLifeShareOptionsGranted | year | 6.09 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | DilutedEarningsLossPerShare | DilutedEarningsLossPerShare | USD/shares | -0.81 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | DisposalsIntangibleAssetsOtherThanGoodwill | DisposalsIntangibleAssetsOtherThanGoodwill | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 20-F | 2025-03-11 | 0001801198-25-000012 |
| ifrs-full | DisposalsPropertyPlantAndEquipment | DisposalsPropertyPlantAndEquipment | USD | 1.70M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | DisposalsRightofuseAssets | DisposalsRightofuseAssets | USD | 300,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | EffectOfExchangeRateChangesOnCashAndCashEquivalents | EffectOfExchangeRateChangesOnCashAndCashEquivalents | USD | 6.10M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | EmployeeBenefitsExpense | EmployeeBenefitsExpense | USD | 492.30M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | Equity | Equity | USD | 1.00B | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 | |
| ifrs-full | EquityAndLiabilities | EquityAndLiabilities | USD | 1.73B | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 | |
| ifrs-full | EquityAttributableToOwnersOfParent | EquityAttributableToOwnersOfParent | USD | 1.02B | 2025-03-31 | 2025 | Q1 | 6-K | 2025-05-13 | 0001801198-25-000021 | |
| ifrs-full | ExpectedDividendAsPercentageShareOptionsGranted | ExpectedDividendAsPercentageShareOptionsGranted | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets | ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets | USD | 2.40M | 2021-01-01 | 2021-12-31 | 2021 | FY | 20-F/A | 2023-02-17 | 0001564590-23-002041 |
| ifrs-full | ExpenseFromSharebasedPaymentTransactionsWithEmployees | ExpenseFromSharebasedPaymentTransactionsWithEmployees | USD | 64.60M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed | ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed | USD | 3.70M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | FinanceCosts | FinanceCosts | USD | 21.40M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | FinanceIncome | FinanceIncome | USD | 40.10M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | FinanceIncomeReceivedClassifiedAsOperatingActivities | FinanceIncomeReceivedClassifiedAsOperatingActivities | USD | 52.00M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | FinanceLeaseReceivables | FinanceLeaseReceivables | USD | 285,000 | 2023-12-31 | 2023 | FY | 20-F | 2024-03-19 | 0001801198-24-000021 | |
| ifrs-full | FinancialAssetsAtAmortisedCost | FinancialAssetsAtAmortisedCost | USD | 1.19B | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 | |
| ifrs-full | FinancialAssetsAtFairValue | FinancialAssetsAtFairValue | USD | 0 | 2024-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 | |
| ifrs-full | FinancialLiabilitiesAtAmortisedCost | FinancialLiabilitiesAtAmortisedCost | USD | 499.80M | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 | |
| ifrs-full | FinancialLiabilitiesAtFairValueThroughProfitOrLoss | FinancialLiabilitiesAtFairValueThroughProfitOrLoss | USD | 0 | 2024-12-31 | 2024 | FY | 20-F | 2025-03-11 | 0001801198-25-000012 | |
| ifrs-full | FinishedGoods | FinishedGoods | USD | 6.80M | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 | |
| ifrs-full | ForeignExchangeGain | ForeignExchangeGain | USD | 109.35M | 2024-01-01 | 2024-12-31 | 2024 | FY | 20-F | 2025-03-11 | 0001801198-25-000012 |
| ifrs-full | GainsLossesOnDisposalsOfPropertyPlantAndEquipment | GainsLossesOnDisposalsOfPropertyPlantAndEquipment | USD | -250,000 | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-08-11 | 0001801198-25-000026 |
| ifrs-full | GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss | GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss | USD | -168.80M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLoss | GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLoss | USD | 0 | 2025-01-01 | 2025-03-31 | 2025 | Q1 | 6-K | 2025-05-13 | 0001801198-25-000021 |
| ifrs-full | GovernmentGrants | GovernmentGrants | USD | 6.69M | 2024-12-31 | 2024 | FY | 20-F | 2025-03-11 | 0001801198-25-000012 | |
| ifrs-full | ImpairmentLossRecognisedInProfitOrLoss | ImpairmentLossRecognisedInProfitOrLoss | USD | 970,000 | 2025-01-01 | 2025-09-30 | 2025 | Q3 | 6-K | 2025-11-12 | 0001801198-25-000031 |
| ifrs-full | ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill | ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill | USD | 0 | 2024-01-01 | 2024-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment | ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipmentIncludingRightofuseAssets | ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipmentIncludingRightofuseAssets | USD | 1.00M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | ImpairmentLossRecognisedInProfitOrLossRightofuseAssets | ImpairmentLossRecognisedInProfitOrLossRightofuseAssets | USD | 1.00M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | ImpairmentLossRecognisedInProfitOrLossTradeReceivables | ImpairmentLossRecognisedInProfitOrLossTradeReceivables | USD | 22,000 | 2020-01-01 | 2020-12-31 | 2021 | FY | 20-F | 2022-03-31 | 0001564590-22-012769 |
| ifrs-full | IncomeTaxesPaidClassifiedAsOperatingActivities | IncomeTaxesPaidClassifiedAsOperatingActivities | USD | 18.40M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | IncomeTaxesPaidRefundClassifiedAsOperatingActivities | IncomeTaxesPaidRefundClassifiedAsOperatingActivities | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | IncomeTaxExpenseContinuingOperations | IncomeTaxExpenseContinuingOperations | USD | 14.20M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | IncreaseDecreaseInCashAndCashEquivalents | IncreaseDecreaseInCashAndCashEquivalents | USD | 615.20M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges | IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges | USD | -26.00M | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-08-11 | 0001801198-25-000026 |
| ifrs-full | IncreaseDecreaseThroughConversionOfConvertibleInstruments | IncreaseDecreaseThroughConversionOfConvertibleInstruments | USD | 240.43M | 2020-01-01 | 2020-12-31 | 2022 | FY | 20-F | 2023-03-30 | 0001801198-23-000019 |
| ifrs-full | IncreaseDecreaseThroughExerciseOfOptions | IncreaseDecreaseThroughExerciseOfOptions | USD | 3.30M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset | IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset | USD | -4,000 | 2019-01-01 | 2019-12-31 | 2020 | FY | 20-F | 2021-04-02 | 0001564590-21-017439 |
| ifrs-full | IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill | IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill | USD | 30,000 | 2024-01-01 | 2024-12-31 | 2024 | FY | 20-F | 2025-03-11 | 0001801198-25-000012 |
| ifrs-full | IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment | IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment | USD | 1.40M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | IncreaseDecreaseThroughSharebasedPaymentTransactions | IncreaseDecreaseThroughSharebasedPaymentTransactions | USD | 64.60M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | IncreaseDecreaseThroughTransfersFromToInvestmentPropertyPropertyPlantAndEquipment | IncreaseDecreaseThroughTransfersFromToInvestmentPropertyPropertyPlantAndEquipment | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities | IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities | USD | 23.70M | 2022-01-01 | 2022-12-31 | 2024 | FY | 20-F | 2025-03-11 | 0001801198-25-000012 |
| ifrs-full | IntangibleAssetsOtherThanGoodwill | IntangibleAssetsOtherThanGoodwill | USD | 1.90M | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 | |
| ifrs-full | InterestExpenseOnBorrowings | InterestExpenseOnBorrowings | USD | 4.50M | 2025-04-01 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-08-11 | 0001801198-25-000026 |
| ifrs-full | InterestExpenseOnDebtInstrumentsIssued | InterestExpenseOnDebtInstrumentsIssued | USD | 24,000 | 2019-01-01 | 2019-12-31 | 2021 | FY | 20-F/A | 2023-02-17 | 0001564590-23-002041 |
| ifrs-full | InterestExpenseOnLeaseLiabilities | InterestExpenseOnLeaseLiabilities | USD | 3.50M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | Inventories | Inventories | USD | 32.00M | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 | |
| ifrs-full | IssuedCapital | IssuedCapital | USD | 100,000 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 | |
| ifrs-full | IssueOfEquity | IssueOfEquity | USD | 218.30M | 2021-01-01 | 2021-06-30 | 6-K | 2021-08-23 | 0001564590-21-045342 | ||
| ifrs-full | KeyManagementPersonnelCompensation | KeyManagementPersonnelCompensation | USD | 18.30M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | KeyManagementPersonnelCompensationSharebasedPayment | KeyManagementPersonnelCompensationSharebasedPayment | USD | 15.50M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | KeyManagementPersonnelCompensationShorttermEmployeeBenefits | KeyManagementPersonnelCompensationShorttermEmployeeBenefits | USD | 2.80M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | KeyManagementPersonnelCompensationTerminationBenefits | KeyManagementPersonnelCompensationTerminationBenefits | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | Liabilities | Liabilities | USD | 731.60M | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 | |
| ifrs-full | LongtermBorrowings | LongtermBorrowings | USD | 0 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 | |
| ifrs-full | LongtermDeposits | LongtermDeposits | USD | 0 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 | |
| ifrs-full | NetAssetsLiabilities | NetAssetsLiabilities | USD | 26.00M | 2020-12-31 | 2020 | FY | 20-F | 2021-04-02 | 0001564590-21-017439 | |
| ifrs-full | NetDeferredTaxLiabilities | NetDeferredTaxLiabilities | USD | 4.24M | 2020-12-31 | 2021 | FY | 20-F/A | 2023-02-17 | 0001564590-23-002041 | |
| ifrs-full | NetForeignExchangeGain | NetForeignExchangeGain | USD | 10.14M | 2023-01-01 | 2023-09-30 | 2023 | Q3 | 6-K | 2023-11-20 | 0001801198-23-000026 |
| ifrs-full | NoncurrentAssets | NoncurrentAssets | USD | 486.60M | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 | |
| ifrs-full | NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts | NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts | USD | 481.60M | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 | |
| ifrs-full | NoncurrentContractLiabilities | NoncurrentContractLiabilities | USD | 0 | 2024-12-31 | 2024 | FY | 20-F | 2025-03-11 | 0001801198-25-000012 | |
| ifrs-full | NoncurrentFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncome | NoncurrentFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncome | USD | 5.00M | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 | |
| ifrs-full | NoncurrentGovernmentGrants | NoncurrentGovernmentGrants | USD | 6.89M | 2025-06-30 | 2025 | Q2 | 6-K | 2025-08-11 | 0001801198-25-000026 | |
| ifrs-full | NoncurrentLeaseLiabilities | NoncurrentLeaseLiabilities | USD | 87.20M | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 | |
| ifrs-full | NoncurrentLiabilities | NoncurrentLiabilities | USD | 95.20M | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 | |
| ifrs-full | NoncurrentPrepayments | NoncurrentPrepayments | USD | 5.00M | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 | |
| ifrs-full | NoncurrentRestrictedCashAndCashEquivalents | NoncurrentRestrictedCashAndCashEquivalents | USD | 0 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 | |
| ifrs-full | NumberOfOutstandingShareOptions | NumberOfOutstandingShareOptions | shares | 3.60M | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 | |
| ifrs-full | NumberOfShareOptionsExercisableInSharebasedPaymentArrangement | NumberOfShareOptionsExercisableInSharebasedPaymentArrangement | shares | 3.39M | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 | |
| ifrs-full | NumberOfShareOptionsExercisedInSharebasedPaymentArrangement | NumberOfShareOptionsExercisedInSharebasedPaymentArrangement | shares | 776,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement | NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement | shares | 82,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | NumberOfShareOptionsGrantedInSharebasedPaymentArrangement | NumberOfShareOptionsGrantedInSharebasedPaymentArrangement | shares | 15,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | NumberOfSharesIssued | NumberOfSharesIssued | shares | 20.81M | 2021-05-13 | 2023 | FY | 20-F | 2024-03-19 | 0001801198-24-000021 | |
| ifrs-full | OtherAdjustmentsToReconcileProfitLoss | OtherAdjustmentsToReconcileProfitLoss | USD | 1.30M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | OtherComprehensiveIncome | OtherComprehensiveIncome | USD | 190.40M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation | OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation | USD | 190.40M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax | OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax | USD | 60.73M | 2025-01-01 | 2025-03-31 | 2025 | Q1 | 6-K | 2025-05-13 | 0001801198-25-000021 |
| ifrs-full | OtherCurrentLiabilities | OtherCurrentLiabilities | USD | 1.00M | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 | |
| ifrs-full | OtherCurrentPayables | OtherCurrentPayables | USD | 3.10M | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 | |
| ifrs-full | OtherEmployeeExpense | OtherEmployeeExpense | USD | 10.60M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | OtherExpenseByFunction | OtherExpenseByFunction | USD | 1.00M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | OtherExpenseByNature | OtherExpenseByNature | USD | 40,000 | 2024-01-01 | 2024-12-31 | 2024 | FY | 20-F | 2025-03-11 | 0001801198-25-000012 |
| ifrs-full | OtherFinanceIncome | OtherFinanceIncome | USD | 601,000 | 2024-01-01 | 2024-12-31 | 2024 | FY | 20-F | 2025-03-11 | 0001801198-25-000012 |
| ifrs-full | OtherGainsLosses | OtherGainsLosses | USD | -164.80M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | OtherIncome | OtherIncome | USD | 63.71M | 2024-01-01 | 2024-12-31 | 2024 | FY | 20-F | 2025-03-11 | 0001801198-25-000012 |
| ifrs-full | OtherInflowsOutflowsOfCashClassifiedAsOperatingActivities | OtherInflowsOutflowsOfCashClassifiedAsOperatingActivities | USD | 1.27M | 2025-01-01 | 2025-09-30 | 2025 | Q3 | 6-K | 2025-11-12 | 0001801198-25-000031 |
| ifrs-full | OtherNoncurrentAssets | OtherNoncurrentAssets | USD | 12.40M | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 | |
| ifrs-full | OtherNoncurrentLiabilities | OtherNoncurrentLiabilities | USD | 8.00M | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 | |
| ifrs-full | OtherNoncurrentNonfinancialAssets | OtherNoncurrentNonfinancialAssets | USD | 12.40M | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 | |
| ifrs-full | OtherPayables | OtherPayables | USD | 2.91M | 2025-03-31 | 2025 | Q1 | 6-K | 2025-05-13 | 0001801198-25-000021 | |
| ifrs-full | OtherReserves | OtherReserves | USD | 1.00B | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 | |
| ifrs-full | OtherRevenue | OtherRevenue | USD | 300,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome | OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome | USD | 7.80M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome | OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome | pure | -0.028 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | ParValuePerShare | ParValuePerShare | USD/shares | 0 | 2021-05-13 | 2023 | FY | 20-F | 2024-03-19 | 0001801198-24-000021 | |
| ifrs-full | PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities | PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities | USD | 3.60M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | PaymentsToAcquireOrRedeemEntitysShares | PaymentsToAcquireOrRedeemEntitysShares | USD | 250,000 | 2020-01-01 | 2020-06-30 | 6-K | 2021-08-23 | 0001564590-21-045342 | ||
| ifrs-full | Prepayments | Prepayments | USD | 1.21M | 2023-12-31 | 2023 | FY | 20-F | 2024-03-19 | 0001801198-24-000021 | |
| ifrs-full | ProceedsFromBorrowingsClassifiedAsFinancingActivities | ProceedsFromBorrowingsClassifiedAsFinancingActivities | USD | 2.87M | 2019-01-01 | 2019-12-31 | 2021 | FY | 20-F/A | 2023-02-17 | 0001564590-23-002041 |
| ifrs-full | ProceedsFromDisposalsOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets | ProceedsFromDisposalsOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 20-F | 2024-03-19 | 0001801198-24-000021 |
| ifrs-full | ProceedsFromExerciseOfOptions | ProceedsFromExerciseOfOptions | USD | 3.30M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | ProceedsFromExerciseOfWarrants | ProceedsFromExerciseOfWarrants | USD | 300.00M | 2021-05-13 | 2023 | FY | 20-F | 2024-03-19 | 0001801198-24-000021 | |
| ifrs-full | ProceedsFromIssueOfOrdinaryShares | ProceedsFromIssueOfOrdinaryShares | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 20-F | 2023-03-30 | 0001801198-23-000019 |
| ifrs-full | ProceedsFromIssueOfPreferenceShares | ProceedsFromIssueOfPreferenceShares | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 20-F | 2023-03-30 | 0001801198-23-000019 |
| ifrs-full | ProceedsFromSalesOrMaturityOfFinancialAssetsMeasuredAtFairValueThroughProfitOrLossClassifiedAsInvestingActivities | ProceedsFromSalesOrMaturityOfFinancialAssetsMeasuredAtFairValueThroughProfitOrLossClassifiedAsInvestingActivities | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 20-F | 2025-03-11 | 0001801198-25-000012 |
| ifrs-full | ProfitLoss | ProfitLoss | USD | -296.80M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity | ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity | USD | -177.03M | 2024-01-01 | 2024-12-31 | 2024 | FY | 20-F | 2025-03-11 | 0001801198-25-000012 |
| ifrs-full | ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects | ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects | USD | -177.03M | 2024-01-01 | 2024-12-31 | 2024 | FY | 20-F | 2025-03-11 | 0001801198-25-000012 |
| ifrs-full | ProfitLossAttributableToOwnersOfParent | ProfitLossAttributableToOwnersOfParent | USD | -100.92M | 2025-01-01 | 2025-03-31 | 2025 | Q1 | 6-K | 2025-05-13 | 0001801198-25-000021 |
| ifrs-full | ProfitLossBeforeTax | ProfitLossBeforeTax | USD | -282.60M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | ProfitLossFromOperatingActivities | ProfitLossFromOperatingActivities | USD | -136.50M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | PropertyPlantAndEquipment | PropertyPlantAndEquipment | USD | 116.30M | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 | |
| ifrs-full | PurchaseOfFinancialAssetsMeasuredAtFairValueThroughProfitOrLossClassifiedAsInvestingActivities | PurchaseOfFinancialAssetsMeasuredAtFairValueThroughProfitOrLossClassifiedAsInvestingActivities | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities | PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities | PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities | USD | 28.60M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | PurchasesOfGoodsRelatedPartyTransactions | PurchasesOfGoodsRelatedPartyTransactions | USD | 14.30M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | RawMaterials | RawMaterials | USD | 24.10M | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 | |
| ifrs-full | RecoverableAmountOfAssetOrCashgeneratingUnit | RecoverableAmountOfAssetOrCashgeneratingUnit | USD | 5.40M | 2024-12-31 | 2024 | FY | 20-F | 2025-03-11 | 0001801198-25-000012 | |
| ifrs-full | RentalIncome | RentalIncome | USD | 13,000 | 2021-01-01 | 2021-12-31 | 2021 | FY | 20-F/A | 2023-02-17 | 0001564590-23-002041 |
| ifrs-full | RepaymentsOfBorrowingsClassifiedAsFinancingActivities | RepaymentsOfBorrowingsClassifiedAsFinancingActivities | USD | 2.87M | 2019-01-01 | 2019-12-31 | 2021 | FY | 20-F/A | 2023-02-17 | 0001564590-23-002041 |
| ifrs-full | ResearchAndDevelopmentExpense | ResearchAndDevelopmentExpense | USD | 414.70M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | RetainedEarnings | RetainedEarnings | USD | 471.20M | 2021-12-31 | 2021 | FY | 20-F | 2022-03-31 | 0001564590-22-012769 | |
| ifrs-full | Revenue | Revenue | USD | 722.52M | 2025-01-01 | 2025-09-30 | 2025 | Q3 | 6-K | 2025-11-12 | 0001801198-25-000031 |
| ifrs-full | RevenueFromContractsWithCustomers | RevenueFromContractsWithCustomers | USD | 1.03B | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | RevenueFromPerformanceObligationsSatisfiedOrPartiallySatisfiedInPreviousPeriods | RevenueFromPerformanceObligationsSatisfiedOrPartiallySatisfiedInPreviousPeriods | USD | 25.13M | 2021-01-01 | 2021-12-31 | 2021 | FY | 20-F | 2022-03-31 | 0001564590-22-012769 |
| ifrs-full | RevenueFromRenderingOfServices | RevenueFromRenderingOfServices | USD | 1.03M | 2018-01-01 | 2018-12-31 | 2020 | FY | 20-F | 2021-04-02 | 0001564590-21-017439 |
| ifrs-full | RevenueFromSaleOfGoods | RevenueFromSaleOfGoods | USD | 3,000 | 2019-01-01 | 2019-12-31 | 2021 | FY | 20-F/A | 2023-02-17 | 0001564590-23-002041 |
| ifrs-full | ReversalOfImpairmentLossRecognisedInProfitOrLossTradeReceivables | ReversalOfImpairmentLossRecognisedInProfitOrLossTradeReceivables | USD | 22,000 | 2021-01-01 | 2021-12-31 | 2021 | FY | 20-F | 2022-03-31 | 0001564590-22-012769 |
| ifrs-full | RightofuseAssets | RightofuseAssets | USD | 285.20M | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 | |
| ifrs-full | ShorttermDepositsClassifiedAsCashEquivalents | ShorttermDepositsClassifiedAsCashEquivalents | USD | 0 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 | |
| ifrs-full | TaxEffectFromChangeInTaxRate | TaxEffectFromChangeInTaxRate | USD | 4.50M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss | TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss | USD | 14.10M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | TaxEffectOfForeignTaxRates | TaxEffectOfForeignTaxRates | USD | 47.00M | 2023-01-01 | 2023-12-31 | 2023 | FY | 20-F | 2024-03-19 | 0001801198-24-000021 |
| ifrs-full | TaxExpenseIncomeAtApplicableTaxRate | TaxExpenseIncomeAtApplicableTaxRate | USD | 46,000 | 2018-01-01 | 2018-12-31 | 2020 | FY | 20-F | 2021-04-02 | 0001564590-21-017439 |
| ifrs-full | TaxRateEffectFromChangeInTaxRate | TaxRateEffectFromChangeInTaxRate | pure | -0.016 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | TaxRateEffectOfAdjustmentsForCurrentTaxOfPriorPeriods | TaxRateEffectOfAdjustmentsForCurrentTaxOfPriorPeriods | pure | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 20-F | 2023-03-30 | 0001801198-23-000019 |
| ifrs-full | TaxRateEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss | TaxRateEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss | pure | -0.05 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | TaxRateEffectOfForeignTaxRates | TaxRateEffectOfForeignTaxRates | pure | -0.09 | 2023-01-01 | 2023-12-31 | 2023 | FY | 20-F | 2024-03-19 | 0001801198-24-000021 |
| ifrs-full | TaxRateEffectOfTaxLosses | TaxRateEffectOfTaxLosses | pure | -0.057 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | TradeAndOtherCurrentPayablesToRelatedParties | TradeAndOtherCurrentPayablesToRelatedParties | USD | 1.80M | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 | |
| ifrs-full | TradeAndOtherPayablesToRelatedParties | TradeAndOtherPayablesToRelatedParties | USD | 1.80M | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 | |
| ifrs-full | TradeAndOtherPayablesToTradeSuppliers | TradeAndOtherPayablesToTradeSuppliers | USD | 83.00M | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 | |
| ifrs-full | TradeAndOtherReceivablesDueFromRelatedParties | TradeAndOtherReceivablesDueFromRelatedParties | USD | 1.70M | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 | |
| ifrs-full | TransactionPriceAllocatedToRemainingPerformanceObligations | TransactionPriceAllocatedToRemainingPerformanceObligations | USD | 303.22M | 2021-12-31 | 2021 | FY | 20-F | 2022-03-31 | 0001564590-22-012769 | |
| ifrs-full | TransfersIntoLevel3OfFairValueHierarchyAssets | TransfersIntoLevel3OfFairValueHierarchyAssets | USD | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 20-F/A | 2023-02-17 | 0001564590-23-002041 |
| ifrs-full | TransfersIntoLevel3OfFairValueHierarchyLiabilities | TransfersIntoLevel3OfFairValueHierarchyLiabilities | USD | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 20-F/A | 2023-02-17 | 0001564590-23-002041 |
| ifrs-full | TransfersOutOfLevel1IntoLevel2OfFairValueHierarchyAssets | TransfersOutOfLevel1IntoLevel2OfFairValueHierarchyAssets | USD | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 20-F/A | 2023-02-17 | 0001564590-23-002041 |
| ifrs-full | TransfersOutOfLevel1IntoLevel2OfFairValueHierarchyLiabilities | TransfersOutOfLevel1IntoLevel2OfFairValueHierarchyLiabilities | USD | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 20-F/A | 2023-02-17 | 0001564590-23-002041 |
| ifrs-full | TransfersOutOfLevel2IntoLevel1OfFairValueHierarchyAssets | TransfersOutOfLevel2IntoLevel1OfFairValueHierarchyAssets | USD | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 20-F/A | 2023-02-17 | 0001564590-23-002041 |
| ifrs-full | TransfersOutOfLevel2IntoLevel1OfFairValueHierarchyLiabilities | TransfersOutOfLevel2IntoLevel1OfFairValueHierarchyLiabilities | USD | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 20-F/A | 2023-02-17 | 0001564590-23-002041 |
| ifrs-full | TransfersOutOfLevel3OfFairValueHierarchyAssets | TransfersOutOfLevel3OfFairValueHierarchyAssets | USD | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 20-F/A | 2023-02-17 | 0001564590-23-002041 |
| ifrs-full | TransfersOutOfLevel3OfFairValueHierarchyLiabilities | TransfersOutOfLevel3OfFairValueHierarchyLiabilities | USD | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 20-F/A | 2023-02-17 | 0001564590-23-002041 |
| ifrs-full | UndiscountedFinanceLeasePaymentsToBeReceived | UndiscountedFinanceLeasePaymentsToBeReceived | USD | 1.67M | 2023-12-31 | 2023 | FY | 20-F | 2024-03-19 | 0001801198-24-000021 | |
| ifrs-full | UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised | UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised | USD | 1.55B | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 | |
| ifrs-full | ValueAddedTaxReceivables | ValueAddedTaxReceivables | USD | 0 | 2022-12-31 | 2022 | FY | 20-F | 2023-03-30 | 0001801198-23-000019 | |
| ifrs-full | WagesAndSalaries | WagesAndSalaries | USD | 417.10M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | WarrantLiability | WarrantLiability | USD | 0 | 2023-12-31 | 2023 | FY | 20-F | 2024-03-19 | 0001801198-24-000021 | |
| ifrs-full | WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 | WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 | USD/shares | 11.148 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 | |
| ifrs-full | WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019 | WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019 | USD/shares | 4.515 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019 | WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019 | USD/shares | 18.285 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019 | WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019 | USD/shares | 19.04 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019 | WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019 | USD/shares | 17.305 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 | WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 | USD/shares | 11.769 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 | |
| ifrs-full | WeightedAverageFairValueAtMeasurementDateShareOptionsGranted | WeightedAverageFairValueAtMeasurementDateShareOptionsGranted | USD | 4.80M | 2023-12-31 | 2023 | FY | 20-F | 2024-03-19 | 0001801198-24-000021 | |
| ifrs-full | WeightedAverageSharePriceShareOptionsGranted2019 | WeightedAverageSharePriceShareOptionsGranted2019 | USD/shares | 13.397 | 2023-01-01 | 2023-12-31 | 2023 | FY | 20-F | 2024-03-19 | 0001801198-24-000021 |
| ifrs-full | WeightedAverageShares | WeightedAverageShares | shares | 368.64M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 |
| ifrs-full | WorkInProgress | WorkInProgress | USD | 1.10M | 2025-12-31 | 2025 | FY | 20-F | 2026-03-10 | 0001801198-26-000008 | |
| us-gaap | OtherIncome | Other Income | USD | 2.74M | 2021-01-01 | 2021-12-31 | 2021 | FY | 20-F/A | 2023-02-17 | 0001564590-23-002041 |